Vertex Pharma (VRTX) revenue was $12.0B in FY2025 (+9% YoY). The tables below show the complete quarterly and annual revenue history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Revenue
Fiscal Year
Revenue
YoY
2025
$12.0B
+9%
2024
$11.0B
+12%
2023
$9.9B
+11%
2022
$8.9B
+18%
2021
$7.6B
+22%
2020
$6.2B
+49%
2019
$4.2B
+37%
2018
$3.0B
+22%
2017
$2.5B
+46%
2016
$1.7B
+65%
2015
$1.0B
+78%
2014
$580M
-52%
2013
$1.2B
-21%
2012
$1.5B
+8%
2011
$1.4B
+884%
2010
$143M
+41%
2009
$102M
-42%
2008
$176M
Recent Quarterly Revenue
Quarter
Revenue
Q1 2026
$3.0B
Q4 2025
$3.2B
Q3 2025
$3.1B
Q2 2025
$3.0B
Q1 2025
$2.8B
Q4 2024
$2.9B
Q3 2024
$2.8B
Q2 2024
$2.6B
Q1 2024
$2.7B
Q4 2023
$2.5B
Q3 2023
$2.5B
Q2 2023
$2.5B
Source: VRTX on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.